申请人:Isis Innovation Limited
公开号:US20020072586A1
公开(公告)日:2002-06-13
Chiral peptide nucleic acids are provided which hybridise strongly with complementary nucleic acids and have potential as antigene and antisense agents and as tools in molecular biology. Compounds with cis-stereochemistry and based on proline and a spacer amino acid have structures (II), (III), where n is 1 or 2-200, B is a protected or unprotected base, R is H or alkyl, aralkyl or heteroaryl and may be substituted, X may be OH, and Y may be H.
提供了手性肽核酸,它们与互补核酸强烈杂交,并具有作为抗原和反义剂的潜力,以及作为分子生物学工具。基于脯氨酸和一个空间氨基酸的具有顺式构型的化合物具有结构(II),(III),其中n为1或2-200,B为受保护或未受保护的碱基,R为H或烷基,芳基烷基或杂环芳基,可以被取代,X可以是OH,Y可以是H。